SCHEMBL15215745

SCHEMBL15215745

Cc1nccc(=O)n1Cc1ccc(Cl)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.52
▸ GAA P10253 1/20 0.52
▸ KDM4E B2RXH2 3/20 0.49
▸ POLB P06746 1/20 0.46
▸ MAPT P10636 1/20 0.46
▸ GALR3 O60755 1/20 0.45
▸ NR2F2 P24468 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ HTT P42858 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ LMNA P02545 1/20 0.45
▸ P2RX3 P56373 2/20 0.45
▸ UBE2N P61088 1/20 0.44
▸ HPGD P15428 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ THRB P10828 1/20 0.42
▸ RGS4 P49798 1/20 0.41
▸ RGS8 P57771 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15015882 0.80 ATM (0.47) ALDH1A1GAAKDM4EPOLBMAPT
SCHEMBL17464947 0.78 KDM4E (0.48) ALDH1A1GAAKDM4EPOLBMAPT
SCHEMBL761973 0.74 CDK4 (0.38) ALDH1A1POLBKMT2AHPGD
SCHEMBL15215749 0.73 ALDH1A1 (0.56) ALDH1A1GAAKDM4EPOLBMAPT
SCHEMBL15215746 0.73 ALDH1A1 (0.56) ALDH1A1GAAKDM4EPOLBMAPT
Hydrochloric Acid SCHEMBL7585345 0.72 ALDH1A1 (0.59) ALDH1A1GAAKDM4EPOLBMAPT
SCHEMBL12596382 0.72 POLB (0.61) ALDH1A1GAAKDM4EPOLBMAPT
SCHEMBL5266802 0.72 CYP11B2 (0.45) ALDH1A1KDM4EPOLBRAB9A
SCHEMBL11719377 0.71 P2RX3 (0.54) ALDH1A1KDM4EPOLBMAPTSMN1; SMN2
SCHEMBL2950629 0.70 LMNA (0.71) ALDH1A1GAAPOLBSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170298058-A1 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE SHIONOGI & CO (JP) 2017-10-19 — — US disclosed
US-9550763-B2 Heterocyclic ring and carbocyclic derivative SHIONOGI & CO., LTD. (JP) 2017-01-24 — — US disclosed
US-9212130-B2 Heterocyclic derivative and pharmaceutical composition comprising the same SHIONOGI & CO., LTD. (JP) 2015-12-15 — — US disclosed
US-20130225596-A1 NOVEL HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME (AS AMENDED) SHIONOGI & CO., LTD. (JP) 2013-08-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170298058-A1 HETEROCYCLIC RING AND CARBOCYCLIC DERIVATIVE P2RX3, P2RX7, P2RX2 ALDH1A1 2515/4885GAA 4737/4885KDM4E 3118/4885
US-20130225596-A1 NOVEL HETEROCYCLIC DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME (AS AMENDED) P2RX3, P2RX6, P2RX2 ALDH1A1 2598/4885GAA 3933/4885KDM4E 4175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback